UGT2B28

UGT2B28 is an endoplasmic reticulum-resident UDP-glucuronosyltransferase that conjugates glucuronic acid onto endogenous steroids and exogenous compounds, with both its cofactor-binding and substrate-binding domains required for catalysis but dispensable for ER and perinuclear membrane localization (PMID:11300766). Functionally, its enzymatic activity sets systemic androgen tone: tumor overexpression correlates with elevated circulating testosterone and DHT, while loss of UGT2B28 gene copies lowers androgen and androgen-glucuronide levels and raises androstenedione, establishing UGT2B28 as a modulator of androgen bioavailability (PMID:26215610). Beyond conjugation, UGT2B28 functions as a tumor-promoting factor in prostate cancer: it physically binds and stabilizes the endocytic adaptor HIP1 to activate AR and EGFR/ERK1/2 signaling, driving proliferation and epithelial-to-mesenchymal transition, with HIP1 knockdown or combined AR/EGFR inhibition abolishing this advantage (PMID:36343786). UGT2B28 expression is itself controlled transcriptionally by full-length AR and the AR-v7 splice variant, and its knockdown impairs organoid formation and xenograft growth in a manner rescued by re-expression, defining a cell-autonomous oncogenic role embedded in an AR feed-forward loop (PMID:35954173).

1. 2001 High

   Established UGT2B28 as a catalytically active glucuronosyltransferase and separated its enzymatic domains from the determinants of its ER localization, defining it as an ER-resident conjugating enzyme.

   Evidence Glucuronidation assays in heterologous expression with domain-deletion isoforms and subcellular localization of all isoforms

   PMID:11300766

   Open questions at the time

   • Specific endogenous steroid substrates and kinetic preferences not fully delineated
   • Physiological tissue context of catalysis not addressed here
2. 2011 Medium

   Distinguished UGT2B28 from the near-identical paralog UGT2B11 by tissue expression, showing UGT2B28 is restricted to breast and adipose and absent from liver.

   Evidence Isoform-specific quantitative RT-PCR across a human tissue panel

   PMID:21679149

   Open questions at the time

   • mRNA expression not linked to protein levels or activity
   • Regulatory basis of the tissue-restricted pattern unknown
3. 2015 Medium

   Connected UGT2B28 enzymatic activity to systemic physiology by demonstrating that its expression and gene copy number track circulating androgen levels in prostate cancer patients.

   Evidence Mass spectrometry of circulating steroids in patients stratified by UGT2B28 copy number plus tumor expression analysis

   PMID:26215610

   Open questions at the time

   • Correlative human data without mechanistic causation in vivo
   • Does not establish whether systemic effects derive from tumor or peripheral metabolism
4. 2022 Medium

   Revealed a non-catalytic, scaffold-like function: UGT2B28 binds and stabilizes HIP1 to activate AR and EGFR/ERK1/2 signaling and drive proliferation and EMT, expanding its role beyond steroid conjugation.

   Evidence Co-immunoprecipitation, HIP1 knockdown, AR/EGFR pharmacological inhibition, and proliferation/EMT rescue assays in prostate cancer cells

   PMID:36343786

   Open questions at the time

   • Whether scaffold function requires catalytic activity not resolved
   • Structural basis of the UGT2B28-HIP1 interaction unknown
   • Single-lab interaction data
5. 2022 Medium

   Placed UGT2B28 within an AR feed-forward circuit and demonstrated cell-autonomous tumor-promoting activity through loss-of-function with rescue.

   Evidence AR/AR-v7 modulation, siRNA knockdown across LNCaP/LAPC-4/VCaP, 3D organoid and xenograft assays with re-expression rescue

   PMID:35954173

   Open questions at the time

   • Direct AR binding to the UGT2B28 promoter not mapped
   • Relative contribution of enzymatic versus scaffold function to tumor growth unresolved

• How UGT2B28's enzymatic conjugating activity, HIP1-scaffold signaling function, and AR-driven transcriptional regulation are mechanistically integrated within a single protein remains unresolved.
• No structural model linking catalytic and scaffold functions
• Causal role of androgen modulation versus signaling in tumor progression not separated